Literature DB >> 20807809

Nucleotide excision repair gene expression after Cisplatin treatment in melanoma.

Nikola A Bowden1, Katie A Ashton, Kelly A Avery-Kiejda, Xu Dong Zhang, Peter Hersey, Rodney J Scott.   

Abstract

Two of the hallmark features of melanoma are its development as a result of chronic UV radiation exposure and the limited efficacy of cisplatin in the disease treatment. Both of these DNA-damaging agents result in large helix-distorting DNA damage that is recognized and repaired by nucleotide excision repair (NER). The aim of this study was to examine the expression of NER gene transcripts, p53, and p21 in melanoma cell lines treated with cisplatin compared with melanocytes. Basal expression of all genes was greater in the melanoma cell lines compared with melanocytes. Global genome repair (GGR) transcripts showed significantly decreased relative expression (RE) in melanoma cell lines 24 hours after cisplatin treatment. The basal RE of p53 was significantly higher in the melanoma cell lines compared with the melanocytes. However, induction of p53 was only significant in the melanocytes at 6 and 24 hours after cisplatin treatment. Inhibition of p53 expression significantly decreased the expression of all the GGR transcripts in melanocytes at 6 and 24 hours after cisplatin treatment. Although the RE levels were lower with p53 inhibition, the induction of the GGR genes was very similar to that in the control melanocytes and increased significantly across the time points. The findings from this study revealed reduced GGR transcript levels in melanoma cells 24 hours after cisplatin treatment. Our findings suggest a possible mechanistic explanation for the limited efficacy of cisplatin treatment and the possible role of UV light in melanoma. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20807809     DOI: 10.1158/0008-5472.CAN-10-0161

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions.

Authors:  Kangsadarn Bennukul; Sucha Numkliang; Vijittra Leardkamolkarn
Journal:  World J Hepatol       Date:  2014-04-27

2.  Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin.

Authors:  Luiz C Godoy; Chase T M Anderson; Rajdeep Chowdhury; Laura J Trudel; Gerald N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

3.  Whole genome sequencing of matched primary and metastatic acral melanomas.

Authors:  Samra Turajlic; Simon J Furney; Maryou B Lambros; Costas Mitsopoulos; Iwanka Kozarewa; Felipe C Geyer; Alan Mackay; Jarle Hakas; Marketa Zvelebil; Christopher J Lord; Alan Ashworth; Meirion Thomas; Gordon Stamp; James Larkin; Jorge S Reis-Filho; Richard Marais
Journal:  Genome Res       Date:  2011-12-19       Impact factor: 9.043

4.  Nucleotide excision repair deficiency in melanoma in response to UVA.

Authors:  Heather C Murray; Vicki E Maltby; Doug W Smith; Nikola A Bowden
Journal:  Exp Hematol Oncol       Date:  2016-02-24

Review 5.  The role of altered nucleotide excision repair and UVB-induced DNA damage in melanomagenesis.

Authors:  Timothy Budden; Nikola A Bowden
Journal:  Int J Mol Sci       Date:  2013-01-09       Impact factor: 5.923

6.  Further evidence of mutational heterogeneity of the XPC gene in Tunisian families: a spectrum of private and ethnic specific mutations.

Authors:  Mariem Ben Rekaya; Manel Jerbi; Olfa Messaoud; Ahlem Sabrine Ben Brick; Mohamed Zghal; Chiraz Mbarek; Ashraf Chadli-Debbiche; Meriem Jones; Mourad Mokni; Hamouda Boussen; Mohamed Samir Boubaker; Becima Fazaa; Houda Yacoub-Youssef; Sonia Abdelhak
Journal:  Biomed Res Int       Date:  2013-07-25       Impact factor: 3.411

7.  Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In Vitro.

Authors:  Ada W Y Leung; Stacy S Hung; Ian Backstrom; Daniel Ricaurte; Brian Kwok; Steven Poon; Steven McKinney; Romulo Segovia; Jenna Rawji; Mohammed A Qadir; Samuel Aparicio; Peter C Stirling; Christian Steidl; Marcel B Bally
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

8.  Sequential decitabine and carboplatin treatment increases the DNA repair protein XPC, increases apoptosis and decreases proliferation in melanoma.

Authors:  Timothy Budden; Andre van der Westhuizen; Nikola A Bowden
Journal:  BMC Cancer       Date:  2018-01-26       Impact factor: 4.430

9.  Pilot early phase II study of decitabine and carboplatin in patients with advanced melanoma.

Authors:  Andre van der Westhuizen; Naomi Knoblauch; Moira C Graves; Richard Levy; Ricardo E Vilain; Nikola A Bowden
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

10.  Nucleotide Excision Repair Factor XPC Ameliorates Prognosis by Increasing the Susceptibility of Human Colorectal Cancer to Chemotherapy and Ionizing Radiation.

Authors:  Liang-Bo Hu; Yin Chen; Xiao-Dong Meng; Pan Yu; Xu He; Jie Li
Journal:  Front Oncol       Date:  2018-07-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.